Clinical Trial Update: The Impact of Lung Cancer-derived Fibroblasts on Mast Cells Activation

View source ↗

Summary

The completed trial evaluated the impact of lung cancer–derived fibroblasts on mast cell activation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Meir Medical Center | Conditions: Lung Cancer | Status: COMPLETED